Drugs / VGX-6150
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02027116 | Jan 2014 → Jul 2015 | chronic hepatitis C virus infection | GeneOne Life Science, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VGX-6150 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027116 ↗ |